Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Ryota Ishiwata"'
Publikováno v:
Women's Health, Vol 20 (2024)
Background: Women with gynecologic disorders requiring a hysterectomy often have co-existing psychiatric diagnoses. A change in the dispensing pattern of antidepressant (AD) and antianxiety (AA) medications around the time of hysterectomy may be due
Externí odkaz:
https://doaj.org/article/c1bf710c5c1b4facbaf9d82ef8a09d74
Autor:
Abdelrahman AlAshqar, Ryota Ishiwata, Chailee Moss, Kathleen M. Andersen, Lisa Yanek, Mark C. Bicket, G. Caleb Alexander, Mostafa A. Borahay
Publikováno v:
Am J Obstet Gynecol
Despite substantial reductions in the past decade, prescription opioids continue to cause widespread morbidity and mortality in the United States. Little is known regarding patterns and predictors of opioid use among women undergoing benign hysterect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74c6a5330d87a43e065cd7099f981647
https://europepmc.org/articles/PMC9253094/
https://europepmc.org/articles/PMC9253094/
Autor:
Takeharu Yamanaka, Yoji Nagai, Ryota Ishiwata, Shigemi Matsumoto, Satoshi Teramukai, Mitsuo Fukushima
Publikováno v:
British Journal of Cancer
Myelosuppression that occurs during chemotherapy has been reported to be a predictor of better survival in patients with breast or lung carcinomas. We evaluated the prognostic implications of chemotherapy-induced neutropenia in advanced gastric carci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b22edec372bdd726cd650a6601e3d4e
https://doi.org/10.1038/sj.bjc.6603831
https://doi.org/10.1038/sj.bjc.6603831
Autor:
Margaret Leversha, Ryota Ishiwata, David R. Shaffer, Semra Olgac, Katia Manova, Andrew Koff, Agnes Viale, Howard I. Scher, Jaya M. Satagopan
Publikováno v:
Proceedings of the National Academy of Sciences. 102:210-215
Reduced p27 levels correlate with poor prognosis in a wide spectrum of human tumors and can accelerate tumorigenesis in mouse tissues. To determine whether p27 deficiency can accelerate tumorigenesis in tissues with inactive Rb and p53 pathways, we e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d9616fd53d2376f87073fa2e90331cf
https://doi.org/10.1073/pnas.0407362102
https://doi.org/10.1073/pnas.0407362102
Autor:
Masanori Fukushima, Takayoshi Kiba, Satoshi Teramukai, Yuichi Takatsuka, Chikashi Ishioka, Shinzaburo Noguchi, Norikazu Masuda, Motohiro Takeda, Noriaki Ohuchi, Takanori Ishida, Kotone Matsuyama, Ryota Ishiwata
Publikováno v:
Cancer Chemotherapy and Pharmacology
Purpose The purpose of this study was to investigate the activity of capecitabine and trastuzumab in patients with HER2-overexpressing metastatic breast caner resistant to both anthracyclines and taxanes. Method From June 2003 and May 2006, 40 female
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44be6ab7fc50ce5b2f3eec1773803cd5
https://pubmed.ncbi.nlm.nih.gov/19082596
https://pubmed.ncbi.nlm.nih.gov/19082596
Autor:
Satoshi Teramukai, Takeharu Yamanaka, Yoji Nagai, Masanori Fukushima, Shigemi Matsumoto, Ryota Ishiwata
Publikováno v:
Oncology. 73(3-4)
Objective: In cancer patients, the balance between neutrophil (N) and lymphocyte (L) cell counts fluctuates with advancing disease. The objective of our study was to determine the prognostic implications of the N/L ratio in the peripheral blood of ga
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f7ce0a8fe8ffc9702a728fd720627c8
https://pubmed.ncbi.nlm.nih.gov/18424885
https://pubmed.ncbi.nlm.nih.gov/18424885
Autor:
Takeharu Yamanaka, Satoshi Teramukai, Yoji Nagai, Masanori Fukushima, Ryota Ishiwata, Shigemi Matsumoto
Publikováno v:
Cancer chemotherapy and pharmacology. 61(2)
To evaluate the comprehensive safety profile of S-1, a promising novel oral fluoropyrimidine derivative, based on large cohort data.Study subjects were identified from a prospective registry of 3,758 advanced gastric cancer patients in Japan. Each pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ec30fb5e0afd376af7be9915e813c3e
https://pubmed.ncbi.nlm.nih.gov/17922276
https://pubmed.ncbi.nlm.nih.gov/17922276
Autor:
Kaoru Kubota, Hirohito Tada, Mitsuo Fukushima, Akihiro Tokoro, Ryota Ishiwata, Satoshi Teramukai, Masaaki Kawahara, Kiyoyuki Furuse
Publikováno v:
Journal of Clinical Oncology. 25:18043-18043
18043 Background: JMTO LC00–03, a randomized trial of VGD versus PC in patients with advanced NSCLC, showed differences between the two treatment groups in response rate (25 vs 37.1%) and regimens’ specific toxicities including taxane-related tox
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b4bc860671dfaca6c152a98b7a7b669c
https://doi.org/10.1200/jco.2007.25.18_suppl.18043
https://doi.org/10.1200/jco.2007.25.18_suppl.18043
Autor:
Mitsuo Fukushima, Ryota Ishiwata, Satoshi Teramukai, Shigemi Matsumoto, Takeharu Yamanaka, Yoji Nagai
Publikováno v:
Journal of Clinical Oncology. 25:15075-15075
15075 Background: Myelosuppression that occurs during chemotherapy has been reported to be a predictor of better survival in patients with breast or lung carcinomas. We evaluated the prognostic implications of chemotherapy-induced neutropenia in adva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b528bf0158470b1e48db2b38d38e1702
https://doi.org/10.1200/jco.2007.25.18_suppl.15075
https://doi.org/10.1200/jco.2007.25.18_suppl.15075
Autor:
Masanori Fukushima, Harue Tada, Tetsu Shinkai, Kaoru Kubota, Akihiro Tokoro, Masaaki Kawahara, Kiyoyuki Furuse, Satoshi Teramukai, Ryota Ishiwata
Publikováno v:
Journal of Thoracic Oncology. (8):S839
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f6da30477ed25e2fb05c5c18b8d35cc